Clinical Trial Update: Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants [Phase 3]

View source ↗

Summary

The document reports Phase 3 results evaluating lot-to-lot consistency of Tritanrix-HepB/Hib-MenAC and its non-inferiority compared with Tritanrix-HepB/Hiberix …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Tritanrix-HepB/Hib-MenAC
• Tritanrix-HepB/Hiberix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Hepatitis B | Phase 3 | Status: COMPLETED